148
· DOS Abstracts
Trends in arthroscopic meniscectomy and meniscal
repair controlled for age, sex and lesion
Helene Rovsing, Cecilie Rovsing, Laura Drustrup, Carsten Mølgaard, Sten
Rasmussen
Orthopaedic Surgery, Aalborg University Hospital
Background:
Previous studies have observed a correlation between arthro-
scopic meniscectomy (APM) and accelerated progression on osteoarthritis, as
well as limited benefits of APM compared to arthroscopic meniscal repair (AMR)
and physiotherapy. Thus, the incitement for choosing APM as treatment for
meniscal lesions is questionable.
Purpose / Aim of Study:
To identify the distribution of AMR and APM over a
3-year period. In addition, the association between surgical procedure and the
following factors was investigated: age, gender, and traumatic or degenerative
lesion.
Materials and Methods:
In this Cohort Study medical records of patients who
had an APM or an AMR between 2011 and 2013 were evaluated retrospec-
tively. The total number of medical records was 1938 (56.1% men and 43.9%
women). Age ranged from 18 to 88 years, mean age 48.6 ± 15.5. The following
indicators were extracted from the medical records: age, gender, and whether
the lesion was traumatic or degenerative.
Findings / Results:
The incidence of AMRs has increased every year from
11.2% in 2011 to 18.1% in 2013. The mean age within the AMR group was
30.3 ± 10.4 and 51.8 ± 13.9 years within the APM group. Both groups were
male- dominant, however, the proportion of men were higher in the AMR group
compared to the APM group. The majority of the lesions in the AMR group was
traumatic (66.7%), whereas the majority of the lesions in the APM group was
degenerative (65.5%).
Conclusions:
APM is the most dominant surgical approach to meniscal lesions,
but the number of AMRs seems to increase every year. However, it remains un-
clear exactly how certain meniscal lesions should be treated in terms of harms
and functional outcome. In conclusion, the long-term outcome and predictors
to the outcome need to be evaluated further.
No conflicts of interest reported
99.